G
CytoMed Therapeutics (GDTC)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About CytoMed Therapeutics (GDTC)
CytoMed Therapeutics Limited is a pre-clinical biopharmaceutical company. The Company is focused on harnessing its licensed proprietary technologies to create cell-based immunotherapies for the treatment of human cancers. The development of its techn... Read more
- USD2.10
- USD2.25
- USD2.07
- USD4.05
- -3.00%
- 0M
- 15.69k
- 8.40k
- 27M
- 1.20
- 8.20%
Stock News
3 hours ago
AeroVironment, Inc. Announces Pricing of Upsized Offerings of Common Stock And 0% Convertible Senior Notes Due 2030
Yahoo
6 hours ago
Kura Oncology: Ziftomenib Shift Towards Newly Diagnosed Mutant AML Patients Bodes Well
SeekingAlpha
yesterday
An upgrade for Apple’s stock? It’s not the endorsement you might think.
MarketWatch
yesterday
Jim Cramer explains how Microsoft, Meta and Nvidia led the Mag 7 pack in the first half of 2025
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
